We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome a... Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs. Show more
CAMBRIDGE, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
-- Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2 clinical trial expected in 2025...
Findings demonstrate ability of PM359 to correct disease-causing mutation in CGD patient blood stem cells, leading to restored immune function in vivo with no off-target edits detected IND for...
CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic...
First-Ever Open IND for Prime Editing Technology PM359 is Prime Medicine’s Ex Vivo Product Candidate Designed to Correct a Prevalent Disease-Causing Mutation of CGD Initial Data Expected in 2025...
-- Presentations include new preclinical data for PM359, further demonstrating ability of Prime Editors to efficiently, reproducibly and durably correct causative mutation of CGD; on track to...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.66 | 28.231292517 | 5.88 | 7.61 | 5.88 | 848798 | 6.72920573 | CS |
| 4 | 2.85 | 60.7675906183 | 4.69 | 7.61 | 4.11 | 866690 | 5.49724279 | CS |
| 12 | -0.74 | -8.93719806763 | 8.28 | 9.77 | 4.11 | 712117 | 6.26923197 | CS |
| 26 | 0.89 | 13.3834586466 | 6.65 | 9.86 | 4.11 | 669459 | 7.04181963 | CS |
| 52 | -6.42 | -45.9885386819 | 13.96 | 17.2 | 4.11 | 559350 | 8.79217925 | CS |
| 156 | -11.43 | -60.2530311017 | 18.97 | 21.7301 | 4.11 | 443519 | 10.30773763 | CS |
| 260 | -11.43 | -60.2530311017 | 18.97 | 21.7301 | 4.11 | 443519 | 10.30773763 | CS |
NY1972
4 weeks ago
jondoeuk
4 weeks ago
jondoeuk
3 months ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
